ELISA Testing for Vaccines

ELISA Testing for Vaccines
 
 
 
 
 
 
ELISA testing for vaccines
 
 
Vaccine Testing
or
USP Guideline
 
Development and Validation of ELISA methods
 
Routine testing of vaccines and other biologics to ensure efficacy and safety requires large numbers of animals, many of which experience pain and distress during testing. Therefore, identification of methods that would reduce or eliminate the need for animal testing for vaccines is a high priority for different organizations. KYMOS develops ELISA methods for vaccines from the scratch or by adapting existing commercial kits. By one hand Relevant Antigen Quantification using an ELISA sandwich of monoclonal antibodies allows to obtain an absolute measurement of the relevant antigen in the drug substance or in the drug product. By the other hand In Vitro Antigen Potency Determination using an inhibition ELISA assay is useful to compare the immunological potency of the test antigen versus the immunological potency of a reference antigen. Once validated, the method can be easily transferred to client’s Quality Control laboratory. If requested, Kymos can provide regular Quality Control testing under GMP for batch release.
 
Learn More
 
 
 
 
Contact
 

Parc Tecnològic del Vallès

Ronda Can Fatjó, 7B

08290 Cerdanyola del Vallès

Barcelona. Spain

 

 

 

 
information
 

www.kymos.com

info@kymos.com

+34 935 481 848

 
Social Media
 
 
 
 
 
You can unsubscribe by clicking the link below.
Unsubscribe